Help advance the understanding and treatment of brain tumors.
Bexion Pharmaceuticals Awarded $2.9MM SBIR Bridge Award by National Cancer Institute to Support Phase I First-in-Human Clinical Trial in Cancer
Bexion Pharmaceuticals has been awarded a Small Business Innovation Research (SBIR) "Bridge Award" by the National Cancer Institute (NCI).
Drug Preserves Cognitive Function After Whole Brain Radiotherapy for Brain Cancer
Research from Emory's Nell Hodgson Woodruff School of Nursing and the Winship Cancer Institute.
Trial Combining Anti-Cancer Drug and Radiotherapy May Lead to Treatment for BrainTumor
Research presented at the 2013 European Cancer Congress
New Approach to Treating Human Brain Cancer Could Lead to Improved Outcomes
Research from Sanford-Burnham's NCI-Designated Cancer Center, led by Robert, Wechsler-Reya, PhD, and ABTA Scientific Advisory Council member.
Promising Therapeutic Target for Meningioma
Research from Johns Hopkins University School of Medicine
Nanodiamonds Deliver Brain Cancer Drugs Safely, UCLA Team Shows
Research from UCLA.
New Magnetic Resonance Analysis Reveals Brain Tumor Response to Anti-angiogenesis Therapy
Research from Martinos Center for Biomedical Imaging at Massachusetts General Hospital.
Inflammatory Protein Converts GBM Cells Into Most Aggressive Version
Conditions in brain tumor environment trigger previously unexplained cellular transition and radiation resistance.
Promising Therapeutic Target for Hard-to-treat Brain Tumor
Research from Johns Hopkins on high-grade meningiomas.
Genes That Drive Brain Cancer Revealed
Information on personalized medicine from Oncology Nurse Advisor.